Tag Results

  • Equivo invests in LexisNexis® Visualfiles™

    Equivo, the newly launched dedicated recoveries business by UK law firm, Shoosmiths LLP and the national collections, recoveries and enforcement business, Chartsbridge, has invested in legal workflow and case management solution, Lexis® Visualfiles™. When fully deployed, the Visualfiles platform will streamline processes end-to-end across the firm’s three service areas – debt collections, recoveries and enforcement; facilitate compassionate engagement with customers and clients; and ensure a leaner, smoother and cost-efficient service.

    Monday, 21 June 2021
  • London Court of International Arbitration invests in LexisNexis® Visualfiles™

    LexisNexis Enterprise Solutions today announced that the London Court of International Arbitration (LCIA), ranked among the top three arbitration institutions globally, is investing in legal workflow and case management system, Lexis®  Visualfiles™. With this deployment, the LCIA will leverage sophisticated technical capabilities to boost business efficiency and enhance the quality of service to its many international users.

    Friday, 18 June 2021
  • Simply Conveyancing is Live on LexisNexis Visualfiles

    LexisNexis Enterprise Solutions today announced that Simply Conveyancing, ranked among the UK’s top property law and conveyancing firms, is live on legal workflow and case management solution, Lexis® Visualfiles™.

    Wednesday, 7 April 2021

Blog


Regulation, growth and access to justice: why legal services need a reset

Well-intentioned consumer protections embedded in the regulation of legal services increasingly act as barriers to innovation, competition and access to justice.


Digital marketing for law firms in 2026 – where to focus your efforts

Digital marketing for law firms in 2026 is more demanding than ever. AI is reshaping content, while audiences are becoming more selective and platforms are raising the bar on quality.


Doug Hargrove

From AI ambition to operational reality

AI is no longer an emerging technology on the horizon. It has become the connective tissue binding law, regulation, risk and commercial decision-making.